Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleInvited Perspective

Imaging PD-L1 Expression in Melanoma Brain Metastases

Sridhar Nimmagadda
Journal of Nuclear Medicine June 2022, 63 (6) 897-898; DOI: https://doi.org/10.2967/jnumed.121.263209
Sridhar Nimmagadda
Russell H. Morgan Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center and Bloomberg–Kimmel Institute for Cancer Immunotherapy, Department of Pharmacology and Molecular Sciences, and Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 6 897-898
DOI 
https://doi.org/10.2967/jnumed.121.263209
PubMed 
34740950

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 22, 2021
  • Revision received November 1, 2021
  • Published online June 1, 2022.

Article Versions

  • previous version (November 5, 2021 - 09:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Preclinical evaluation and preliminary clinical study of 68Ga-NODAGA-NM-01 for PET imaging of PD-L1 expression
    Lingzhou Zhao, Jiali Gong, Sisi Liao, Wenhua Huang, Jinhua Zhao, Yan Xing
    Cancer Imaging 2025 25 1

Article usage

Article usage: December 2021 to May 2025

AbstractFullPdf
Nov 20210047
Dec 2021009
Jan 2022009
Feb 2022002
Mar 2022006
Apr 2022006
May 20220015
Jun 2022053575
Jul 2022035719
Aug 2022019518
Sep 2022026014
Oct 2022020620
Nov 202209728
Dec 2022037521
Jan 2023038212
Feb 2023035621
Mar 2023035220
Apr 2023026012
May 2023019812
Jun 2023022416
Jul 202302279
Aug 2023030320
Sep 2023025620
Oct 2023011715
Nov 202308011
Dec 202305113
Jan 202401718
Feb 2024019712
Mar 202409842
Apr 202406030
May 202403910
Jun 202405532
Jul 2024010011
Aug 202409117
Sep 202402718
Oct 20240105
Nov 202401311
Dec 202402716
Jan 20250299
Feb 20250799
Mar 20250368
Apr 202502518
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (6)
Journal of Nuclear Medicine
Vol. 63, Issue 6
June 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging PD-L1 Expression in Melanoma Brain Metastases
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging PD-L1 Expression in Melanoma Brain Metastases
Sridhar Nimmagadda
Journal of Nuclear Medicine Jun 2022, 63 (6) 897-898; DOI: 10.2967/jnumed.121.263209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging PD-L1 Expression in Melanoma Brain Metastases
Sridhar Nimmagadda
Journal of Nuclear Medicine Jun 2022, 63 (6) 897-898; DOI: 10.2967/jnumed.121.263209
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
  • Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine
  • Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
Show more INVITED PERSPECTIVE

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire